Article citationsMore>>

Haroche, J., Amoura, Z., Trad, S.G., Wechsler, B., Cluzel, P., Grenier, P.A. and Piette, J.C. (2006) Variability in the Efficacy of Interferon-α in Erdheim-Chester Disease by Patient and Site of Involvement: Results in Eight Patients. Arthritis & Rheumatology, 54, 3330-3336.
https://doi.org/10.1002/art.22165

has been cited by the following article:

• TITLE: Thirty-Four Months Control of Frail Patient with Multisystemic Affection Proved Erdheim Chester Disease: A Case Report

  AUTHORS: Emad Mohsen Barsoum, Fiby Samir Boules, May Gamal Ashour, Mohsen Samy Barsoum

  KEYWORDS: Erdheim-Chester Disease, Histiocytoses, Non-Langerhans Cell Histiocytoses

  JOURNAL NAME: Journal of Cancer Therapy, Vol.12 No.12, December 13, 2021

  ABSTRACT: Erdheim-Chester disease (ECD) is a rare non-Langerhans form of histiocytosis characterized by multisystemic involvement. We report a case of a 51-year-old male patient treated with pegylated IFN-α in a monthly schedule with low-dose prednisolone and achieved 34 months of control with minimal side effects.